Dose-Modulated Sonidegib Therapy for Periocular Basal Cell Carcinoma

NCT07068568 · clinicaltrials.gov ↗

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Basal Cell Cancer
Eyelid Tumor
Basal Cell Carcinoma (BCC)
Basal Cell Carcinoma of the Head and Neck

Interventions

DRUG: Sonidegib

Sponsor

Federico II University